Vertical Aerospace Stock Discussion

I WILL UPDATE IF I FIND MORE
$Poseida Therapeutics (PSTX.US)$ ✔️TOP PLAY. To be acquired by Roche for $1.5B for $9.00/share. “Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash”
$Citius Pharmaceuticals (CTXR.US)$✔️  News halt after hours + PR today o...

$Vertical Aerospace (EVTL.US)$Vertical Aerospace | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mudrick Capital Management, L.P.(10.7%),Mudrick Capital Management, LLC(10.7%), etc.
SEC
27 mins ago
Vertical Aerospace | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STEPHEN FITZPATRICK(74.98%),IMAGINATION AERO INVESTMENT LTD.(19.03%)
SEC
07:52

$Vertical Aerospace (EVTL.US)$
creeping up here

$60 Degrees Pharmaceuticals (SXTP.US)$ $Sintx Technologies (SINT.US)$ $Kindly MD (KDLY.US)$ $AgEagle Aerial Systems (UAVS.US)$ $S&W Seed (SANW.US)$ $SmartKem (SMTK.US)$ $SCWorx (WORX.US)$ $Unusual Machines (UMAC.US)$ $PTL Ltd (PTLE.US)$ $NextTrip (NTRP.US)$ $ZenaTech (ZENA.US)$ $Vertical Aerospace (EVTL.US)$ $Vast Renewables (VSTE.US)$ $Wearable Devices (WLDS.US)$
📊⚡️📊

$Vertical Aerospace (EVTL.US)$ Reuters
3 mins ago
Vertical Aerospace : Remaining Loan Repayment Date Extended to Dec. 2028
Vertical Aerospace : Fixes Conversion Price for Remaining Outstanding Convertible Notes at $3.50/Share
Vertical Aerospace : Transaction Expected to Add About $180 Mln to Balance Sheet
Vertical Aerospace Secures up to $50 Mln Funding Commitment From Mudrick Capital

$SU Group Holdings (SUGP.US)$ $The OLB Group (OLB.US)$ $Pineapple Financial (PAPL.US)$ $Pluri Inc (PLUR.US)$ $Agrify (AGFY.US)$ $SemiLEDs (LEDS.US)$ $Advent Technologies (ADN.US)$ $Protagenic Therapeutics (PTIX.US)$ $Vertical Aerospace (EVTL.US)$ $Genprex (GNPX.US)$ $LogicMark (LGMK.US)$ $BTC Digital (BTCT.US)$
📊⚡️📊

$Vertical Aerospace (EVTL.US)$
VX4 Achieves Major Milestone With Launch of Phase 2 of Piloted Flight Testing
Vertical Aerospace [NYSE: EVTL] has achieved a significant milestone as its VX4 prototype begins Phase 2 of piloted flight testing, successfully completing untethered vertical take-off and landing. The prototype, powered by battery packs delivering up to 1.4 MW of peak power, has completed nearly 90 test points and measured 35,000 flight parameters.
Following the UK Civil Aviation Auth...

$Revelation Biosciences (REVB.US)$ $Nukkleus (NUKK.US)$ $Lm Funding America (LMFA.US)$ $Sonoma Pharmaceuticals (SNOA.US)$ $Vertical Aerospace (EVTL.US)$ $Advent Technologies (ADN.US)$ $Avalon Holdings (AWX.US)$ $LakeShore Biopharma (LSB.US)$ $Vicarious Surgical (RBOT.US)$ $Protagenic Therapeutics (PTIX.US)$ $Cingulate (CING.US)$ $BTC Digital (BTCT.US)$ $SemiLEDs (LEDS.US)$ $SU Group Holdings (SUGP.US)$
📊⚡️📊